**Alcohol Use Disorder Breakthrough: Targeting Kappa Opioid Receptors Reduces Drinking in Animal Models**
Boca Raton, Florida – A recent study conducted at the Scripps Research Institute has unveiled promising results in the treatment of alcohol use disorder (AUD). Researchers have identified a compound, LY2444296, that targets the kappa opioid receptor, showing significant potential in reducing alcohol consumption in animal models of alcohol dependence. This breakthrough offers hope for individuals struggling with AUD by honing in on the brain’s KOP system, known to play a crucial role in addiction …